^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BN-Brachyury

    i
    Associations
    News

    Trials

    Company:
    Bavarian Nordic
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) (NCT02179515)
    Phase 1
    National Cancer Institute (NCI)
    Completed
    Last update posted :
    01/26/2021
    Initiation :
    06/28/2014
    Primary completion :
    04/06/2017
    Completion :
    02/28/2018
    CD8 • IFNG • TNFA • IL2 • ICAM1 • IL10 • CD27 • LAMP1 • CD58 • CD40LG • IL4
    |
    ER positive • EGFR mutation • CD8 expression
    |
    BN-Brachyury